Northwest Biotherapeutics Inc (QB) (NWBO) News

27…I think that’s pretty much the whole multi ID gang here which begs the question…Who are the other 50,000+ shareholders and why don’t they seem at all concerned with proper governance or dilution?

I’m sure it might help a percentage, but it also means the GBM revenue model has been cut by 75%. How the company can keep that hidden from investors is beyond me. But I guess that’s why LP never offers up numbers / q calls, instead letting the disciple here do all the talking.

That’s all well and good but you do realize NWBO was a no-show…which is pretty bizarre.

Remember this one? LOL

Wow, 27 likes in a few hours. This post should be stickied,

Senti, can you please do so before you rot in hell as BB and many other "longs" hope?

Moderators are over zealous, made a post that was true , no swearing and deleted right away, wtf.

Yes there is about 27 of us now who compare notes. It's a very fun group chat. Myself and 6 others work at BIDMC so we are very excited about the Dana Farber merger. Mostly everyone works in healthcare, a few with pharmaceutical R& D backgrounds, and two engineering graduates from MIT and Northeastern. 

All 80 sites? Sounds unnecessary, but the stock should start floating up as word of mouth
Regardless of exactly what is up with this last inspection story, the idea that all 80 sites must be inspected by law is nonsense.

Also, inspections are not limited to trial sites, They can include mfg facilities, the CDMOs, and any other site that is in the database chain.

All 80 sites? Sounds unnecessary, but the stock should start floating up as word of mouth.

I was just wondering if your co-workers are part of the NWBO ride.

Thats for the data.

LC, when I posted the same years ago I was roasted for it. Dr. Liau has said this for years but few want to acknowledge it. But it does imo help a % of gbm patients very much especially mesenchymal

That was a fantastic conference from what I've been told. My co-worker's husband who oversaw a Charles River lab here in MA attended. He's not with Charles River anymore. Dana Farber and BIDMC are working towards building a new hospital here in Boston,  he's working on that now. 

https://www.dana-farber.org/about/dana-farber-beth-israel-deaconess-cancer-collaboration


Beth Israel has some great doctors, Harvard medical affiliated. Gotta love Harvard, Carol's over there too.

https://bioethics.hms.harvard.edu/faculty-staff/carol-l-powers


 

Don't feel completely ignored. 

This one I posted here a while back. It was completely ignored, of course.

>>Early studies showed the safety of the vaccine is acceptable, and subsequent research revealed that some patients survived far longer than expected. "The issue is that it doesn't work for everyone," Dr. Liau says. "We're still trying to find out what are the biomarkers of response in these patients? Which patients will respond well and which won't? And is there a way to detect that ahead of time so we can pick out the 25 percent of patients we know will be helped?"

Agree. That, so far, is the stupidist post of the day and obviously scripted by a paid pumper to support mute inept nonmanagement.

I think Starric posted some stuff the disciples here had hoped to suppress.

https://web.hansonwadegroup.com/rs/355-DOS-429/images/Personalized%20Cancer%20Vaccine%20Summit.pdf

Does anybody know how to translate Advent into Portuguese?

Lucky thing they didn’t sell their facility to the Chinese. 🙄

I'm resharing what Chiugray posted, and I'm of the same opinion. Makes sense and sounds plausible. A second CHM took place in December asking for a check-the-box or verification of a matter the CHM requested, as a conditional item for recommendation for approval. That would mean a 3rd CHM meeting is not required, plausible.


In further support of this opinion, trial site Inspections aren't just a formality for cya purposes, but rather it's established UK law. Assuming that the MHRA has decided to "approve DCVAX," still, it's mandatory to have all the inspection sites sign-off on. There were 80 international sites, which means not 79, but all 80 must be completed.

Yeah same 😅

If I was around during the 0.14-0.17 days maybe I'd have a little more as well, unfortunately I started buying $1+

Yea...no idea how y'all are wealthy enough to accumulate 2m, let alone 500k or more shares.

I'm happy with my baby-sized position 😅.

whosleftholdindabag You do realize the all time high was in the area of 12-15 bucks.

I genuinely believe that by this time next month, $NWBO will not only be trading at 52-week highs but at all-time highs as well. .

Lololol

You've been a long long time basher of the stock and it's long followers

I appreciate the contributions that Senti and a few others have made to the $NWBO board over the years! I genuinely believe that by this time next month, $NWBO will not only be trading at 52-week highs but at all-time highs as well. While it may not have been leaked intentionally, we've had a glimpse behind the curtain and are now just waiting for the MHRA approval to be made public! I've prayed for this moment every night for a long time, and I’m extremely glad that this much-needed therapy will soon be accessible to patients, now that its therapeutic and life-extending benefits have been verified. I have also formed dear friendships with people on this board who have suffered for too long, and they will finally achieve financial security! GLTA

3x is still impressive!

... it's only 30x my position 😅

So Senti should rot in hell? I don't see how her, or DD's comments, hurt anyone. If anything, it's nice to know that we're that close to the finish line, finally.

BB, you do realize that the poster suggesting this inspection is one of the board's very long term long posters that nearly always supports the company.

100% on Fe!

I rarely respond to the lies of the bashers because they do not deserve my time or attention, but in this case, I am compelled by my compassion for the tireless work of all 22 of Northwest' employees to commercialize DCVax-L platform technology and deliver their life extending cancer treatments to patients in need. Whomever started the rumor that the MHRA conducted a last minute inspection on the last day of January should rot in Hell !!! I know that statement is a complete and utter lie and was designed to further hurt the already suffering cancer patients and their families.What kind of inhuman mindset would allow anyone to try to create that kind of fear and confusion???

The truth is that the company is and has been productively and successfully engaged with the MHRA in the very complex application process since day one and has earned the respect and trust of the MHRA by refusing to respond to the baseless lies of the bashers and haters. All involved in this process of delivering Northwest' breakthrough technology to patients in need understand the value of DCVax-L treatments and are determined to make their treatments available to patients worldwide.

Cheers,

BB

Excellent DD starric! Thanks for sharing.

10baggerz, congratulations on your trade in selling and buying back so much lower. That is a lot of shares, over 3x compared to my position. I sincerely hope you become very wealth very soon!

NANSIG (Neurology and Neurosurgery Interest Group) is excited to announce that Professor Keyoumars Ashkan (MD, FRCP, FRCPath, FRCS(SN)) will be speaking at the NANSIG Annual Conference 2025!

This was officially announced on February 5, and the conference will take place on February 22-23.
I’m curious to learn about the topic of his presentation!

Feb.5, 2025
NANSIG (Neurology and Neurosurgery Interest Group)
@NANSIG1
NANSIG CONFERENCE 2025: SPEAKER ANNOUNCEMENT

We are honoured to welcome Professor Keyoumars Ashkan (MD, FRCP, FRCPath, FRCS(SN)) to the NANSIG Annual Conference 2025!


NANSIG (Neurology and Neurosurgery Interest Group)
@NANSIG1
·
Feb 5
Join us for an insightful session with one of the most distinguished neurosurgeons in the field. Secure your spot today!
https://x.com/NANSIG1/status/1887214517441957946

Thank you for sharing this information starric.

It is also interesting to note that Brazil (ANVISA) is already a participating Project Orbis partner with the U.S. (FDA):



https://www.fda.gov/about-fda/oncology-center-excellence/project-orbis

3headdog - For one, BRICS was an idea that was, and has failed to materialize. It's OT so I'll leave it there. The Russian and Chinese Gov't's are strapped for cash. Vaccine commerce BTW Gov't's strapped for cash is not viable.

Perhaps Flaskworks, simplifying the process, is not that far from reality?

The US is far from the Pinnacle of "provided" health care. We do awesome at research, elite education of Doctors, and some top notch medical centers. We don't do so well at delivery of health care. And the FDA/Big Pharma arrangements and Americans paying often double or triple what others around the world pay for drugs is part of that. Also the reason the company went the route of England and the MHRA is very well documented. Don't sell countries like Brazil, or Russia, or even China short when it comes to "provided" health care for its citizens. Hell back in the 80's and 90's Cuba was considered a model for providing basic health care to its citizens while many Americans had no wellness care, no pregnancy care, etc. Sometimes you have to dig beyond surface appearances.

What... strategic decision? You gotta be kidding me with your BS. I see if you are a pumper, you can claim all kind of BS no matter how ridiculous it is.

think management is not reaching into their own pockets to buy because of a strategic decision made years ago that only allows their ownership through investor approved compensation or through bridge loans for lack of reasonable funding opportunities.

Latest Brazil patent was posted by Henry on Sep 27, 2024

@HenryMuney
$NWBO Notice of allowance on August 30, 2024 🇧🇷 BR112017028602 - "Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response"

Next steps, payment and grant.

https://x.com/HenryMuney/status/1839690688243314927

Don't we have patents issued there.

Brazil is part of BRICS- and Russia has been developing both Dendritic and MRna vaccines in parallel course as the west.
https://link.springer.com/article/10.1007/s11060-023-04559-1 The restrictions (sanctions) on Russia have built their research channels into China partnerships where reverse engineering and scientific engagement has allowed this lockstep. A major hurdle is the correct immunosuppresor- which combo works ( Dcvax leads this race )- this being the reason to cite as a goal. I do not see the intent by Brazil to use our vaccine, but to use a much cheaper Russian developed one that will piggyback on our discoveries as they advance.

Thanks Captain..

This is good DD, but the bill still needs to be passed and then implemented. Brazil is still a border-line 3rd world country...I have never been but my very good friend is from Sao Paulo....he still visits every year a few times and says the same thing. Just like Bidens "Moonshot", this mostly likely will yield nothing, it probably wont even be passed as it would be too expensive for a country like Brazil to absorb financially.

I have a novel idea that WOULD lead to substantial revenue for NW: Apply for approval with the US FDA. All this other BS is just that = BS.

Thanks for sharing starric !
Very nice piece.

GLTU

Link To keep up with the progress of the bill:-

Bill No. 126 of 2025
Summary:
"Institutes the Regulatory Framework for Vaccines and High-Cost Cancer Medications in Brazil and creates standards for the development, research, production, distribution and access to cancer vaccines, with a focus on scientific innovation, universal access and equity in the Unified Health System (SUS), and establishes guidelines for promoting research, national production and international collaboration"

https://www.congressonacional.leg.br/materias/materias-bicamerais/-/ver/pl-126-2025

. Art. 6 ANVISA shall have a maximum period of 6 months to issue a conclusive opinion on the approval of vaccines and high-cost cancer medications, starting from the formal request for registration.

You are wrong, the last remain gap is $0.

National priority in Brazil FEDERAL SENATE
BILL
No. 126, OF 2025

Very very soon! Nice DD! Starric’

Establishes the Regulatory Framework for Vaccines and High-Cost Medicines Against Cancer in Brazil and creates standards for the development, research, production, distribution and access to vaccines against cancer, with a focus on scientific innovation, universal access and equity in the Unified Health System (SUS), and establishes guidelines for promoting research, national production and international collaboration. AUTHORSHIP: Senator Dr. Eudócia (PL/AL)
Page of the article
Separate copy of PL 126/2025 [1 of 10]
SF/25180.18178-57
FEDERAL SENATE
Office of Senator Dr. Eudócia
BILL NO. , OF 2025
Institutes the Regulatory Framework for Vaccines and High-Cost Cancer Medications in Brazil and creates standards for the development, research, production, distribution and access to vaccines against cancer, with a focus on scientific innovation, universal access and equity in the Unified Health System (SUS), and establishes guidelines for the promotion of research, national production and international collaboration. THE NATIONAL CONGRESS decrees:
CHAPTER I
GENERAL PROVISIONS
Art. 1º The Regulatory Framework for Vaccines and High-Cost Cancer Medications is hereby established with the objective of promoting research, development, production and distribution of vaccines and cancer medications in Brazil, ensuring universal and equal access to all citizens, in accordance with the principles of the Unified Health System (SUS).
Art. 2º Vaccination and high-cost cancer medications shall be a national priority, based on the following principles:
I - Scientific and technological innovation;
II - Safety and efficacy;
III - Universal and equitable access; Signed electronically by Sen. Dra. Eudócia
A separate copy of Bill 126/2025 To verify the signatures, go to https://legis.senado.gov.br/autenticadoc-legis/3867876777
[2 of 10]
SF/25180.18178-57
FEDERAL SENATE
Office of Senator Dra. Eudócia
IV - Continuous training of health professionals;
V - Sustainable development and national production.
CHAPTER II
PROMOTION OF RESEARCH AND INNOVATION
Art. 3º The National Fund for Research and Innovation in Oncology
(FUNPIO) is hereby created, with the objective of financing research, projects and studies
related to the development of vaccines and the national production of
high-cost drugs against cancer in Brazil.
Sole paragraph. The fund will be composed of:
I - Budgetary resources of the Union;
II - Contributions from private and public companies and non-governmental organizations (NGOs);
III - International partnerships in scientific research;
IV - Other funds allocated to FUNPIO.
Art. 4º The Executive Branch will create a program to encourage research in oncology, including:
I - Financing of basic and applied research projects;
II - Partnerships with universities and research centers, public and private;
III - Encouragement of the creation of biotechnology startups focused on vaccines and high-cost cancer drugs;
IV - Encouragement of the use of artificial intelligence (AI) in the research and development of vaccines and high-cost cancer drugs;
V - Encouragement of the use and sequencing of DNA, allowing advances in the identification of cancer and the personalization of treatment. Signed electronically by Sen. Dra. Eudócia
Avulso do PL 126/2025 [3 de 10]
To verify the signatures, go to https://legis.senado.gov.br/autenticadoc-legis/3867876777
SF/25180.18178-57
FEDERAL SENATE
Office of Senator Dra. Eudócia
CHAPTER III
REGULATION AND APPROVAL OF VACCINES AND
MEDICATIONS
Art. 5º The National Health Surveillance Agency (ANVISA) will establish
an accelerated and specific process for the evaluation, approval and registration of
vaccines and high-cost drugs against cancer, taking into
consideration:
I - Their efficacy and safety, according to the clinical studies and trials
conducted; II - Transparency in the approval process, with the publication of technical opinions and opinions from independent scientific committees; III - Analysis of the cost-benefit of vaccines and high-cost cancer medications for public health. Art. 6 ANVISA shall have a maximum period of 6 months to issue a conclusive opinion on the approval of vaccines and high-cost cancer medications, starting from the formal request for registration. CHAPTER IV UNIVERSAL ACCESS AND DISTRIBUTION Art. 7 The SUS shall be responsible for the free and universal distribution of vaccines and high-cost cancer medications to the entire Brazilian population, with priority given to: I - Patients at High Risk of Cancer (Preventive Vaccines); II - Patients with Localized or Initial Cancer (Therapeutic Vaccines); III - Patients with Advanced or Metastatic Cancer; IV - Patients with metastatic melanoma (Experimental Vaccines
Associated with Immunotherapeutics);
Signed electronically by Sen. Dra. Eudócia
Apart from PL 126/2025 [4 of 10]

lol smarter ??
My ROI on other stocks in lastv10 years has been 400-500%
And in NWBO -90%
So I would prefer less smarter 

Jackxkr,

I think management is not reaching into their own pockets to buy because of a strategic decision made years ago that only allows their ownership through investor approved compensation or through bridge loans for lack of reasonable funding opportunities. I also think this is part of the reason more has not been said about the good news turned into bad and the reason for the screening hold. Best wishes.

Yes I agree, large bags of money holders
very soon